Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.36 +0.39 (+1.47%)
Streaming Delayed Price Updated: 11:01 AM EDT, Mar 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition
On this Wednesday, March 25, 2026, the biotechnology sector has been electrified by the announcement that Merck & Co. (NYSE: MRK) will acquire Terns Pharmaceuticals, Inc. (NASDAQ: TERN) in an all-cash... 
Via Finterra
Topics Initial Public Offering Intellectual Property World Trade
News headline image
Sarepta Therapeutics (SRPT) at a Crossroads: A 2026 Deep Dive into the Future of Genetic Medicine
As of March 25, 2026, Sarepta Therapeutics (NASDAQ: SRPT) stands at a pivotal, albeit bruising, crossroads in the history of genetic medicine. Once the darling of the biotechnology sector for its... 
Via Finterra
Topics Economy Intellectual Property Retirement
News headline image
Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience
As of March 25, 2026, Merck & Co., Inc. (NYSE: MRK) stands at a pivotal crossroads in its 135-year history. Known globally as a titan of oncology and vaccines, the Rahway, New Jersey-based... 
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
Pfizer Inc. (NYSE:PFE) Shows Strong Technical Setup for Potential Breakout ↗
Via Chartmill
Stay informed about the most active stocks in the S&P500 index on Tuesday's session. ↗
Via Chartmill
News headline image
Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer To Rally More Than 34%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Analysts change ratings & price targets for HSCS, ONDS, STRO, PFE, HST, CABA, INSM, PVH. See full list & how others rate each stock. 
Via Benzinga
News headline image
Bristol-Myers Squibb Shares Jump 3.3% on Robust 2026 Guidance and High Dividend Yield
Shares of pharmaceutical giant Bristol-Myers Squibb (NYSE:BMY) climbed 3.3% in early trading on Monday, March 23, 2026, after the company issued a surprisingly robust financial outlook for the fiscal... 
Via MarketMinute
Topics Economy Initial Public Offering Intellectual Property
News headline image
Pfizer Stock Is Doing Something It Hasn't Done Since 2022 ↗
Up until recently, the stock has been a chronic underperformer. 
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
5 High-Yield Stocks to Shield Your Portfolio From the Storm ↗
Via MarketBeat
News headline image
Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive ↗
Valneva stock drops after Phase 3 Lyme vaccine misses primary endpoint; secondary data shows efficacy as Pfizer backs regulatory submissions. 
Via Benzinga
News headline image
Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
Dow futures up 1000 points. Valneva stock falls in pre-market. Pfizer and Valneva announce Phase 3 results for Lyme disease vaccine. Other stocks also down. 
Via Benzinga
Topics Stocks
News headline image
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
From Pfizer Inc.
Via Business Wire
News headline image
Have $500? 2 Healthcare Stocks Long-Term Investors Should Buy Right Now ↗
You can get in on these market giants for bargain prices today. 
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Unpopular Stocks That Should Get More Attention and 1 We Avoid
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t... 
Via StockStory
Topics Supply Chain
News headline image
Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC
From Pfizer Inc.
Via Business Wire
News headline image
My Top 3 Drug Stocks for March 2026 ↗
These companies have impressive track records of navigating the biggest challenges in their industry. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Pfizer vs Moderna: Which Pharma Stock Has More Upside? ↗
They aren't just "pandemic stocks." 
Via The Motley Fool
Topics Intellectual Property
Which S&P500 stocks are the most active on Thursday? ↗
Via Chartmill
News headline image
Follow the Footprints: 3 Stocks with Unusual Options Activity That You Can’t Ignore
On a day when nothing worked for investors, yesterday’s unusual options activity had plenty of variety, especially in the top three. Here’s how investors might have played each of the stock's and their... 
Via Barchart.com
Topics Economy Stocks
News headline image
Is It Too Late to Buy Eli Lilly? ↗
Eli Lilly's GLP-1 drugs are leaders in a new and exciting drug category, but investors already know this fact. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Looking for Safety and Yield as Oil Prices Whip Saw? This Stock Has You Covered.
As oil prices rise with increasing global uncertainty, this pharmaceutical stock emerges as a possible safe haven for income investors. 
Via Barchart.com
Topics Earnings
News headline image
Pfizer Combo Therapy Scores Major Win In Prostate Cancer Trial ↗
Pfizer (PFE) shares rise as Talzenna/Xtandi combo hits primary goal in Phase 3 prostate cancer trial. See the full TALAPRO-3 results. 
Via Benzinga
News headline image
TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
From Pfizer Inc.
Via Business Wire
Looking for the most active stocks in the S&P500 index on Wednesday? ↗
Via Chartmill
News headline image
The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms
In the face of the most aggressive antitrust environment in decades and the sweeping legislative changes of the 2025 "One Big Beautiful Bill Act" (OBBBA), the healthcare sector has not retreated from... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
The Best Healthcare Stocks to Buy With $50 Right Now ↗
Even on a budget, you can get quality stocks. 
Via The Motley Fool
News headline image
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Zoetis (NYSE:ZTS)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Zoetis (NYSE:ZTS) and its peers. Looking ... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
Tuesday's session: most active stock in the S&P500 index ↗
Via Chartmill
News headline image
The Grand Divergence: Finance Surges as Health Care Braces for a Historic Q1 Earnings Slump
As the first quarter of 2026 draws to a close, the S&P 500 is witnessing one of the most dramatic sector performance splits in recent financial history. According to consensus estimates as of March 17,... 
Via MarketMinute
Topics Earnings Economy Initial Public Offering
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.